Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong 510080, China;
State Ministry of Education Key Laboratory of Tropical Diseases Control Research, Sun Yat-sen University, Guangzhou, Guangdong 510080, China;
Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong 510080, China;
State Ministry of Education Key Laboratory of Tropical Diseases Control Research, Sun Yat-sen University, Guangzhou, Guangdong 510080, China;
NewBiomed PIKA (Guangzhou) Ltd. Guangzhou International Business Incubator Block-A, A1210 Unit Guangzhou Science Park Guangzhou,Guangdong 510663, China;
Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong 510080, China;
State Ministry of Education Key Laboratory of Tropical Diseases Control Research, Sun Yat-sen University, Guangzhou, Guangdong 510080, China;
NewBiomed PIKA (Guangzhou) Ltd. Guangzhou International Business Incubator Block-A, A1210 Unit Guangzhou Science Park Guangzhou,Guangdong 510663, China;
Guangdong Medical Laboratory Animal Center 119, Boyan Road Huangqi Distric, Nanhai Foshan, Guangdong 528248, China;
NewBiomed PIKA (Guangzhou) Ltd. Guangzhou International Business Incubator Block-A, A1210 Unit Guangzhou Science Park Guangzhou,Guangdong 510663, China;
Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong 510080, China;
State Ministry of Education Key Laboratory of Tropical Diseases Control Research, Sun Yat-sen University, Guangzhou, Guangdong 510080, China;
PIKA; adjuvant; Toll like receptor; HBsAg; vaccine; dendritic cell;